Ab Index-Nr. 616-111-00-8

Index-Nr.Internationale chemische BezeichnungEG-Nr.CAS-Nr.EinstufungKennzeichnungbis 30.11.2018: Spezifische Konzentrations-
grenzen,
M-Faktoren
ab 01.12.2018: Spezifische Konzentrations-
grenzen
M-Faktoren und ATE
Anmer-
kungen
Gefahrenklasse, Gefahren-
kategorie und Gefahren-
kodierung
Kodierung der Gefahrenhin-
weise
Piktogramm, Kodierung der SignalworteKodierung der Gefahrenhin-
weise
Kodierung der ergänzenden Gefahren-
merkmale
616-111-00-8fenhexamid (ISO);
N-(2,3-dichlor-4-hydroxy-
phenyl)-1-methyl-
cyclohexancarboxamid
422-530-5126833-17-8Aquatic Chronic 2H411GHS09H411   
616-112-00-3oxasulfuron (ISO);
oxetan-3-yl 2-[(4,6-dimethyl-
pyrimidin-2-yl)-carbamoyl-
sulfamoyl]benzoate
144651-06-9STOT RE 2 (*)
Aquatic Acute 1
Aquatic Chronic 1
H373 (*)(*)
H400
H410
GHS08
GHS09
Wng
H373 (*)(*)
H410
   
616-113-00-9desmedipham (ISO);
ethyl 3-phenylcarbamoyl-
oxyphenylcarbamate
237-198-513684-56-5Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410 M = 10 
616-114-00-4dodecanamide, N,N'-
(9,9',10,10'-tetrahydro-
9,9',10,10'-tetraoxo(1,1'-
bianthracene)-4,4'-diyl)bis-
418-010-2136897-58-0Aquatic Chronic 4H413H413   
616-115-00-XN-(3-acetyl-2-hydroxyphenyl)-
4-(4-phenylbutoxy)benzamide
416-150-9136450-06-1Aquatic Chronic 4H413H413   
616-116-00-5N-(4-dimethylaminopyri-
dinium)-3-methoxy-4-(1-
methyl-5-nitroindol-3-yl-
methyl)-N-(o-tolylsulfonyl)ben-
zamidate
416-790-9143052-96-4Aquatic Chronic 4H413H413   
616-117-00-0N-[2-(3-acetyl-5-nitrothiophen-
2-ylazo)-5-diethylamino-
phenyl]acetamide
416-860-9777891-21-1Repr. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H361f
(*)(*)(*)
H317
H400
H410
GHS08
GHS09
Wng
H361f
(*)(*)(*)
H317
H410
   
616-118-00-6N-(2',6'-dimethylphenyl)-2-
piperidinecarboxamide hydrochloride
417-950-065797-42-4Acute Tox. 4 (*)
Aquatic Chronic 3
H302
H412
GHS07
Wng
H302
H412
   
616-119-00-12-(1-butyl-3,5-dioxo-2-
phenyl-(1,2,4)-triazolidin-
4-yl)-4,4-dimethyl-3-oxo-
N-(2-methoxy-5-(2-(dodecyl-
1-sulfonyl))propionylamino)-
phenyl)-pentanamide
418-060-5118020-93-2Aquatic Chronic 4H413H413   
616-120-00-7reaction mass of:
N-(3-dimethylamino-4-
methyl-phenyl)-benzamide;
N-(3-dimethylamino-2-methyl-
phenyl)-benzamide;
N-(3-dimethylamino-3-methyl-
phenyl)-benzamide
420-600-1STOT RE 2 (*)
Aquatic Chronic 2
H373 (*)(*)
H411
GHS08
GHS09
Wng
H373 (*)(*)
H411
   
616-121-00-22,4-dihydroxy-N-(2-methoxy-
phenyl)benzamide
419-090-1129205-19-2Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411
   
616-122-00-8methyl-neodecanamide414-460-9105726-67-8Acute Tox. 4 *H302GHS07
Wng
H302   
616-123-00-3N-[3-[[4-(diethylamino)-2-
methylphenyl]imino]-6-oxo-
1,4-cyclohexadienyl]acetamide
414-740-096141-86-5Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410   
616-124-00-9lithium bis(trifluoromethyl-
sulfonyl)imide
415-300-090076-65-6Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Skin Corr. 1B
Aquatic Chronic 3
H311
H301
H373 **
H314
H412
GHS06
GHS05
GHS08
Dgr
H311
H301
H373 **
H314
H412
   
616-125-00-43-cyano-N-(1,1-dimethyl-
ethyl)androsta-3,5-diene-
17-β-carboxamide
415-730-9151338-11-3Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410   
616-126-00-X1-methyl-4-nitro-3-propyl-1H-
pyrazole-5-carboxamide
423-960-6139756-01-7Acute Tox. 4 *
STOT RE 2 *
Aquatic Chronic 3
H302
H373 **
H412
GHS08
GHS07
Wng
H302
H373 **
H412
   
616-127-00-5reaction mass of:
N,N'-Ethane-1,2-diylbis(de-
canamide);
12-Hydroxy-N-[2-[1-oxy-
decyl)amino]ethyl]octa-
decanamide;
N,N'-Ethane-1,2-diylbis(12-
hydroxyoctadecanamide)
430-050-2Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411
   
616-128-00-0N-(2-(1-allyl-4,5-dicyanoimi-
dazol-2-ylazo)-5-(dipropylami-
no)phenyl)-acetamide
417-530-7123590-00-1Aquatic Chronic 4H413H413   
616-129-00-6N,N'-bis(2,2,6,6-tetramethyl-
4-piperidyl)isophthalamide
419-710-042774-15-2Acute Tox. 4
Eye Irrit. 2
H302
H319
GHS07
Wng
H302
H319
   
616-130-00-1N-(3-(2-(4,4-dimethyl-2,5-
dioxo-imidazolin-1-yl)-4,4-
dimethyl-3-oxo-pentanoyl-
amino)-4-methoxy-phenyl)-
octadecanamide
421-780-2150919-56-5Aquatic Chronic 4H413H413   
616-131-00-71-aminocyclopentane-
carboxamide
422-950-917193-28-1STOT RE 1
Acute Tox. 4 *
Eye Dam. 1
H372 **
H302
H318
GHS05
GHS08
GHS07
Dgr
H372 **
H302
H318
   
616-132-00-2N-[4-(4-cyano-2-furfurylidene-
2,5-dihydro-5-oxo-3-furyl)phe-
nyl]butane-1-sulfonamide
423-250-6130016-98-7Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410   
616-133-00-8N-cyclohexyl-S,S-dioxo-
benzo[b]tiophene-2-
carboxamide
423-990-1149118-66-1Acute Tox. 4 (*)
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H318
H400
H410
GHS05
GHS07
GHS09
Dgr
H302
H318
H410
   
616-134-00-33,3'-bis(dioctyloxyphos-
phinothioylthio)-N,N'-oxy-
bis(methylene)dipropionamide
401-820-5793710-14-2Aquatic Chronic 3H412H412   
616-135-00-9(3S,4aS,8aS)-2-[(2R,3S)-3-
amino-2-hydroxy-4-phenyl-
butyl]-N-tert-butyldecahydroi-
soquinoline-3-carboxamide
430-230-0136522-17-3Acute Tox. 4 (*)
Aquatic Chronic 3
H302
H412
GHS07
Wng
H302
H412
   
616-136-00-4reaction product of
cocoalkyldiethanolamides and
cocoalkylmonoglycerides and
molybdenumtrioxide
(1.75-2.2: 0.75-1.0:0.1-1.1)
430-380-7Aquatic Chronic 2H411GHS09H411   
616-137-00-X4-dichloroacetyl-1-oxa-4-
azaspiro[4,5]decane
401-130-471526-07-3Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411
   
616-138-00-5benzoic acid, N-tert-butyl-N´-
(4-chlorobenzoyl)hydrazide
431-600-4112226-61-6Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411
   
616-139-00-0(3S,4aS,8aS)-N-tert-butyl-
decahydro-3-isoquinoline-
carboxamide
420-380-5136465-81-1Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 3
H302
H318
H412
GHS05
GHS07
Dgr
H302
H318
H412
   
616-140-00-6N,N´´-(methylenedi-4,1-
phenylene)bis[N´-(4-
methylphenyl)urea]
429-380-1133336-92-2Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413
   
616-141-00-1zoxamide (ISO);
(RS)-3,5-dichloro-N-(3-chloro-1-
ethyl-1-methyl-2-oxopropyl)-p-
toluamide
156052-68-5Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410
 M = 10 
616-142-00-71,3-Bis(vinylsulfonylace-
tamido)propane
428-350-393629-90-4Muta. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3
H341
H318
H317
H412
GHS08
GHS05
GHS07
Dgr
H341
H318
H317
H412
   
616-143-00-2N,N'-dihexadecyl-N,N'-bis(2-
hydroxyethyl)propanediamide
422-560-9149591-38-8Repr. 2
Eye Irrit. 2
Aquatic Chronic 4
H361f
(*)(*)(*)
H319
H413
GHS08
Wng
H361f
(*)(*)(*)
H319
H413
   
616-144-00-83,4-dichloro-N-[5-chloro-4-[2-[4-
dodecyloxyphenylsulfonyl]
butyramido]-2-
hydroxyphenyl]benzamide
431-130-1Aquatic Chronic 4H413H413   
616-145-00-3pethoxamide (ISO);
2-chloro-N-(2-ethoxyethyl)-N-(2-
methyl-1-phenylprop-1-
enyl)acetamide
106700-29-2Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H317
H400
H410
GHS07
GHS09
Wng
H302
H317
H410
 M = 100 
616-146-00-9N-(2-methoxy-5-
octadecanoylaminophenyl)-2-
(3-benzyl-2,5-dioxoimidazo-
lidin-1-yl)-4,4-dimethyl-3-
oxopentanoic acidamide
431-330-7142776-95-2Aquatic Chronic 4H413H413   
616-147-00-41-methyl-4-(2-methyl-2H-
tetrazol-5-yl)-1H-pyrazole-5-
sulfonamide
424-160-1139481-22-4Acute Tox. 4 *
Aquatic Chronic 3
H302
H412
GHS07
Wng
H302
H412
   
616-148-00-XN-[6,9-dihydro-9-[[2-hydroxy-1-
(hydroxymethyl)ethoxy]methyl]-
6-oxo-1H-purin-2-yl]acetamide
424-550-184245-12-5Carc. 1B
Muta. 1B
Repr. 1B
H350
H340
H360FD
GHS08
Dgr
H350
H340
H360FD
   
616-150-00-0(2R,3S)-N-(3-amino-2-hydroxy-4-
phenylbutyl)-N-isobutyl-4-
nitrobenzenesulfonamide
hydrochloride
425-260-6STOT RE 2 *
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2
H373 **
H318
H317
H411
GHS05
GHS08
GHS07
GHS09
Dgr
H373 **
H318
H317
H411
   
616-151-00-6N-(2-amino-4,6-dichloro-
pyrimidin-5-yl)formamide
425-650-6171887-03-9Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3
H302
H318
H317
H412
GHS05
GHS07
Dgr
H302
H318
H317
H412
   
616-152-00-14-(4-fluorophenyl)-2-(2-methyl-1-
oxopropyl)-4-oxo-3,
N-diphenylbutanamide
425-850-3125971-96-2Aquatic Chronic 4H413H413   
616-153-00-74-methyl-3-oxo-N-phenyl-2-
(phenylmethylene)pentanamide
425-860-8125971-57-5Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411
   
616-154-00-23,4-dichloro-N-[5-chloro-4-[2-
[4-(hexadecyloxy)phenyl-
sulfonyl]butyramido]-2-
hydroxyphenyl]benzamide
431-110-0Aquatic Chronic 4H413H413   
616-155-00-8N,N,N´,N´-tetracyclohexyl-1,3-
benzenedicarboxamide
431-040-0104560-40-9Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410   
616-156-00-36-(2-chloro-6-cyano-4-
nitrophenylazo)-4-methoxy-3-
[N-(methoxycarbonylmethyl)-N-
(1-methoxycarbonylethyl)amino]
acetanilide
430-500-8204277-61-2Aquatic Chronic 4H413H413   
616-157-00-93-amino-4-hydroxy-N-(3-
isopropoxypropyl)benzene-
sulfonamide hydrochloride
427-780-9114565-70-7Acute Tox. 4 *
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H318
H400
H410
GHS05
GHS07
GHS09
Dgr
H302
H318
H410
   
616-158-00-4N-[4-cyano-3-trifluoromethyl-
phenyl]methacrylamide
427-880-290357-53-2STOT RE 2 *
Aquatic Chronic 2
H373 **
H411
GHS08
GHS09
Wng
H373 **
H411
   
616-160-00-52,2´-azobis[N-(2-hydroxy-
ethyl)-2-methylpropionamide]
429-090-361551-69-7Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412
   
616-161-00-02,4-dichloro-5-hydroxy-
acetanilide
429-110-067669-19-6Aquatic Chronic 3H412H412   
616-162-00-6isostearic acid
monoisopropanolamide
431-540-9Skin Irrit. 2
Aquatic Chronic 2
H315
H411
GHS07
GHS09
Wng
H315
H411
   
616-163-00-14,4´-methylenebis[N-(4-
chlorophenyl)-3-
hydroxynaphthalene-2-
carboxamide]
430-350-3192463-88-0Aquatic Chronic 4H413H413   
616-164-00-7dimoxystrobin (ISO);
(E)-2-(methoxyimino)-N-
methyl-2-[α-(2,5-
xylyloxy)-o-tolyl]acetamide
149961-52-4Carc. 2
Repr. 2
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H351
H361d ***
H332
H400
H410
GHS08
GHS07
GHS09
Wng
H351
H361d ***
H332
H410
 M = 10 
616-165-00-2beflubutamid (ISO);
(RS)-N-benzyl-2-(α,α,α,4-
tetrafluoro-m-tolyoxy)buty-
ramide
113614-08-7Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410 M = 100 
616-166-00-8cyazofamid (ISO);
4-chloro-2-cyano-N,N-
dimethyl-5-p-tolylimidazole-
1-sulfonamide
120116-88-3Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410 M = 10 
616-167-00-3N,N-dibutyl-(2,5-dihydro-5-
thioxo-1H-tetrazol-1-yl)ace-
tamide
418-290-6168612-06-4Eye Irrit. 2
Skin Sens. 1
H319
H317
GHS07
Wng
H319
H317
   
616-168-00-91-dimethylcarbamoyl-4-(2-
sulfonatoethyl)pyridinium
418-440-0136997-71-2Skin Sens. 1H317GHS07
Wng
H317   
616-169-00-44-[4-(2,2-dimethyl-
propanamido)]phenylazo-3-(2-
chloro-5-(2-(3-pentadecyl-
phenoxy)butylamido)
anilino)-1-(2,4,6-trichloro-
phenyl)-2-pyrazoline-5-one
420-220-492771-56-7Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413
   
616-170-00-X(2R)-2-amino-2-phenyl-
acetamide
420-370-06485-67-2Eye Irrit. 2
Skin Sens. 1
H319
H317
GHS07
Wng
H319
H317
   
616-171-00-52-(para-chlorophenyl)glyci-
neamide
420-830-0102333-75-5Eye Dam. 1
Skin Sens. 1
H318
H317
GHS05
GHS07
Dgr
H318
H317
   
616-172-00-0N-(2,2,6,6-tetramethyl-1-
oxylpiperidin-4-yl)acetamide;
(4-acetamido-2,2,6,6-tetra-
methyl-1-piperidinyl)oxidanyl
423-840-314691-89-5Acute Tox. 4 *H302GHS07
Wng
H302   
616-174-00-12-butyl-1,3-diazaspiro[4.4]non-
1-en-4-one hydrochloride
424-560-4151257-01-1Acute Tox. 4 *
Eye Irrit. 2
H302
H319
GHS07
Wng
H302
H319
   
616-175-00-72-(2-hexyldecyloxy)benzamide431-230-3202483-62-3Aquatic Chronic 4H413H413   
616-176-00-23-N,N-bis(methoxyethyl)
aminoacetanilide
432-530-724294-01-7Acute Tox. 4 *
Aquatic Chronic 3
H302
H412
GHS07
Wng
H302
H412
   
616-177-00-8(3-(4-(2-(butyl-(4-
methylphenylsulfonyl)amino)
phenylthio)-5-oxo-1-(2,4,6-
trichlorophenyl)-4,5-dihydro-1H-
pyrazole-3-ylamino)-4-
chlorophenyl)tetradecanamide;
N-[3-({4-[(2-{butyl[(4-
methylphenyl)sulfonyl]amino}
phenyl)thio]-5-oxo-1-(2,4,6-
trichlorophenyl)-4,5-dihydro-1H-
pyrazol-3-yl}amino)-4-
chlorophenyl]tetradecanamide
432-970-1217324-98-6Aquatic Chronic 4H413H413   
616-178-00-3N-(5-(bis(2-methoxyethyl)ami-
no)-2-((2-cyano-4,6-dinitro-
phenyl)-azo)phenyl)acetamide
434-500-952583-35-4Aquatic Chronic 4H413H413   
616-179-00-92-chloro-N-(4-
methylphenyl)acetamide
435-170-916634-82-5Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H318
H317
H400
H410
GHS05
GHS07
GHS09
Dgr
H318
H317
H410
   
616-180-00-4N,N-(dimethylamino)thio-
acetamide hydrochloride
435-470-127366-72-9Repr. 1B
Aquatic Acute 1
Aquatic Chronic 1
H360D ***
H400
H410
GHS08
GHS09
Dgr
H360D ***
H410
   
616-181-00-X4´-methyldodecane-1-
sulfonanilide
435-490-917417-32-2Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410   
616-182-00-5N´-(1,3-dimethylbutylidene)-3-
hydroxy-2-naphthohydrazide
435-860-1214417-91-1Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411
   
616-183-00-0N-dodecyl-4-methoxy-
benzamide
442-340-61854-15-5Aquatic Chronic 4H413H413   
616-184-00-63-methyl-N-(5,8,13,14-tetra-
hydro-5,8,14-trioxonaphth[2,3-
c]acridin-6-yl)benzamide
442-560-2105043-55-8Aquatic Chronic 4H413H413   
616-186-00-7N,N´-(2-chloro-1,4-phenyle-
ne)bis(3-oxobutaneamide)
443-010-453641-10-4Aquatic Chronic 3H412H412   
616-188-00-82-(5,5-dimethyl-2,4-dioxo-
oxazolidin-3-yl)-4,4-dime-
thyl-3-oxo-N-(2-methoxy-5-
octadecanoylaminophe-
nyl)pentanoic acid amide
443-980-9221215-20-9Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413
   
616-189-00-3N-[5-(bis-(2-methoxy-ethyl)-
amino]-2-(6-bromo-2-methyl-
1,3-dioxo-2,3-dihydro-1H-
isoindol-5-ylazo)-
phenyl]acetamide
444-780-4452962-97-9Aquatic Chronic 4H413H413   
616-190-00-9N-decyl-4-nitrobenzamide445-880-064026-19-3Aquatic Chronic 4H413H413   
616-191-00-42-ethyl-N-methyl-N-(3-
methylphenyl)butanamide
446-190-2406488-30-0Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2
H302
H319
H315
H317
H411
GHS07
GHS09
Wng
H302
H319
H315
H317
H411
   
616-192-00-X2-[2-(3-butoxypropyl)-1,1-
dioxo-1,2,4-benzothiadiazin-
3-yl]-5´-tertbutyl-2-(5,5-di-
methyl-2,4-dioxo-1,3-
oxazolidin-3-yl)-2´-[(2-
ethylhexyl)thio]acetanilide
448-060-0727678-39-9Aquatic Chronic 4H413H413   
616-193-00-5N-[2-(2-butyl-4,6-dicyano-1,3-
dioxo-2,3-dihydro-1H-isoindol-
5-ylazo)-5-diethylamino-
phenyl]acetamide
449-940-7368450-39-9Aquatic Chronic 4H413H413   
616-194-00-02,2-diethoxy-N,N-dimethyl-
acetamide
449-950-134640-92-1Eye Irrit. 2H319GHS07
Wng
H319   
616-196-00-1disodium salt of
1-hydroxy-4-(β-(4-
(1-hydroxy-3,6-disulfo-8-
acetylamino-2-naphthyl-
azo)phenoxy)ethoxy)-N-
dodecyl-2-naphthamide
419-990-4Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410   
616-197-00-7reaction mass of: potassium
N-[3-(dimethyloxi-
doamino)propyl]-
1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-
heptadecafluorooctane sulfonamidate;
N-[3-(dimethyloxi-
doamino)propyl]-
1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-
heptadecafluorooctane sulfonamide
422-500-1STOT RE 2 *H373 **GHS08
Wng
H373 **   
616-198-00-21,3-bis[12-hydroxy-octade-
camide-N-methylene]-benzene
423-300-7Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413
   
616-200-00-1reaction mass of N,N´-ethane-
1,2-diylbis(hexanamide) and 12-hydroxy-N-[2-[(1-oxyhe-
xyl)amino]ethyl]octadecana­
mide and N,N´-ethane-1,2-
diylbis(12-hydroxyocta-
decan amide)
432-430-3 Aquatic Chronic 4H413 H413   
616-201-00-712-hydroxyoctadecanoic acid,
reaction products with
1,3-benzenedimethanamine
and hexamethylenediamine
432-840-2220926-97-6Acute Tox. 4 *
Aquatic Chronic 4
H332
H413
GHS07
Wng
H332
H413
   
616-202-00-2reaction mass of: 2,2´-[(3,3´-
dichloro[1,1´-biphenyl]-4,4´-
diyl)bis(azo)]bis[N-(2,4-
dimethylphenyl)]-3-oxo-
butanamide;
2-[[3,3´-dichloro-4´-[[1[[(2,4-
dimethylphenyl)amino]car-
bonyl]-2-oxopropyl]azo][1,1´-
biphenyl]-4-yl]azo]-N-(2-
methylphenyl)-3-oxo-
butanamide;
2-[[3,3´-dichloro-4´-[[1[[(2,4-
dimethylphenyl)amino]car-
bonyl]-2-oxopropyl]azo][1,1´-
biphenyl]-4-yl]azo]-N-(2-
carboxylphenyl)-3-oxo-
butanamide
434-330-5Carc. 2
Skin Sens. 1
Aquatic Chronic 4
H351
H317
H413
GHS08
GHS07
Wng
H351
H317
H413
   
616-203-00-8reaction mass of: N-[5-[bis-(2-
methoxyethyl)amino]-2-(2-
butyl-4,6-dicyano-1,3-dioxo-
2,3-dihydro-1H-isoindol-5-yl-
azo)phenyl]acetamide;
N-[2-(2-butyl-4,6-dicyano-
1,3-dioxo-2,3-dihydro-1H-
isoindol-5-ylazo)5-
diethylaminophenyl]acetamide
442-280-0Aquatic Chronic 4H413H413   
616-204-00-3N,N´´-(methylenedi-4,1-
phenylene)bis[N´-octylurea]
451-060-3122886-55-9Aquatic Chronic 4H413H413   
616-205-00-9Metazachlor (ISO);
2-chloro-N-(2,6-dimethylphe-
nyl)-N-(1H-pyrazol-1-ylme-
thyl)acetamide
266-583-067129-08-2Skin Sens. 1B
Carc. 2
Aquatic Acute 1
Aquatic Chronic 1
H317
H351
H400
H410
GHS07
GHS08
GHS09
Wng
H317
H351
H410
 M = 100
M = 100
 
616-206-00-4flufenoxuron (ISO);
1-(4-(2-cloro-α,α,α-p-trifluoro-
tolyloxy)-2-fluorophenyl)-3-(2,6-
difluorobenzolyl)urea
417-680-3101463-69-8Lact.
Aquatic Acute 1
Aquatic Chronic 1
H362
H400
H410
GHS09
Wng
H362
 
H410
 M = 10000
M = 10000
 
bis 28.02.2018
616-207-00-X
polyhexamethylene biguanide
hydrochloride
 27083-27-8 or 32289-58-0Carc. 2
Acute Tox. 4
STOT RE 1
 
Eye Dam. 1
Skin Sens. 1B
Aquatic Acute 1
Aquatic Chronic 1
H351
H302
H372
(Atemwege) (Inhalation)
H318
H317
H400
H410
GHS05
GHS07
GHS08
 
GHS09
Dgr
H351
H302
H372
(Atemwege) (Inhalation)
H318
H317
 
H410
 M = 10
M = 10
 
ab 01.03.2018*):
*) Die harmonisierten Einstufungen dürfen bereits vor dem genannten Datum verwendet werden.
616-207-00-X
Polyhexamethylen-bi-
guanid-hydrochlorid;
PHMB
 32289-58-0
27083-27-8
Carc. 2
Acute Tox. 2
Acute Tox. 4
STOT RE 1
Eye Dam. 1
Skin Sens. 1B
Aquatic Acute 1
Aquatic Chronic 1
H351
H330
H302
H372
(Atemwege)
(Einatmen)
H318
H317
H400
H410
GHS08
GHS06
GHS05
GHS09
Dgr
H351
H330
H302
H372
(Atemwege)
(Einatmen)
H318
H317
H410
 M = 10
M = 10
 
616-208-00-5N-ethyl-2-pyrrolidone;
1-ethylpyrrolidin-2-one
220-250-62687-91-4Repr. 1BH360DGHS08
Dgr
H360D   
616-209-00-0amidosulfuron (ISO);
3-(4,6-dimethoxypyrimidin-2-
yl)- 1-((N-methyl-N-methyl-
sulfonylamino)sulfonyl)urea
407-380-0120923-37-7Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
 
H410
 M = 100
M = 100
 
616-210-00-6tebufenpyrad (ISO);
N-(4-tertbutylbenzyl)-4-chloro-
3-ethyl-1-methyl-1Hpyrazole-
5-carboxamide
 119168-77-3Acute Tox. 3
Acute Tox. 4
STOT RE 2
 
Skin Sens. 1B
Aquatic Acute 1
Aquatic Chronic 1
H301
H332
H373
Ma­gen-Darm-Trakt) (oral)
H317
H400
H410
GHS06
GHS08
GHS09
 
 
Dgr
H301
H332
H373
Ma­gen-Darm-Trakt) (oral)
H317
 
H410
 M = 10
M = 10
 
616-211-00-1proquinazid (ISO);
6-iodo-2-propoxy-3-propyl-
quinazolin-4(3H)-one
 189278-12-4Carc. 2
Aquatic Acute 1
Aquatic Chronic 1
H351
H400
H410
GHS08
GHS09
Wng
H351
 
H410
 M = 1
M = 10
 
616-212-00-73-iodo-2-propynyl
butylcarbamate;
3-iodoprop-2-yn-1-yl
butylcarbamate
259-627-555406-53-6Acute Tox. 3
Acute Tox. 4
STOT RE 1
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H331
H302
H372
(Kehlkopf)
H318
H317
H400
H410
GHS06
GHS08
GHS05
GHS09
Dgr
H331
H302
H372
(Kehlkopf)
H318
H317
H410
 M = 10
M = 1
 
616-213-00-2Mandipropamid (ISO); 2-(4- Chlorphenyl)-N-{2-[3-methoxy-4-(prop-2-yn-1-yloxy) phenyl]ethyl}-2-(prop-2-yn-1- yloxy)acetamid374726-62-2Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410 M = 1
M = 1
 
616-214-00-8Metosulam (ISO); N-(2,6-Dichlor-3-
methylphenyl)-5,7-
dimethoxy[1,2,4]tria-
zolo[1,5-a] pyrimidin-2-
sulfonamid
139528-85-1Carc. 2
STOT RE 2
Aquatic Acute 1
Aquatic Chronic 1
H351
H373
(Augen, Nieren)
H400
H410
GHS08
GHS09
Wng
H351
H373
(Augen, Nieren)
H410
 M = 1000
M = 100
 
616-215-00-3Dimethenamid-P (ISO); 2- Chlor-N-(2,4-dimethyl-3-thienyl)-N-[(2S)-1-methoxypropan- 2-yl]acetamid163515-14-8Acute Tox. 4
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H317
H400
H410
GHS07
GHS09
Wng
H302
H317
H410
 M = 10
M = 10
 
616-216-00-9Flonicamid (ISO); N-(Cyanomethyl)-
4-(trifluormethyl)pyridin-3-
carboxamid
158062-67-0Acute Tox. 4H302GHS07
Wng
H302   
616-217-00-4Sulfoxaflor (ISO); [Methyl(oxo) {1-[6-(trifluormethyl)-3-
pyridyl]ethyl}-λ6-sulfanyliden] cyanamid
946578-00-3Acute Tox. 4
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410
 M = 1
M = 1
 
ab 01.03.2018*):
*) Die harmonisierten Einstufungen dürfen bereits vor dem genannten Datum verwendet werden.
616-218-00-X
Benzovindiflupyr (ISO);
N-[9-(Dichlormethy-
len)-1,2,3,4-tetrahydro-
1,4-methanonaphtha-
lin-5-yl]-3-(difluorme-
thyl)-1-methyl-1H-pyra-
zol-4-carbonsäureamid
1072957-71-1Acute Tox. 3
Acute Tox. 3
Aquatic Acute 1
Aquatic Chronic 1
H331
H301
H400
H410
GHS06
GHS09
Wng
H331
H301
H410
 M = 100
M = 100
 
ab 01.03.2018*):
*) Die harmonisierten Einstufungen dürfen bereits vor dem genannten Datum verwendet werden.
616-219-00-5
Fluopyram (ISO);
N-{2-[3-Chlor-5-(trifluorme-
thyl)pyridin-2-yl]ethyl}-
2-(trifluormethyl)benzamid
658066-35-4Aquatic Chronic 2H411GHS09 H411   
ab 01.03.2018*):
*) Die harmonisierten Einstufungen dürfen bereits vor dem genannten Datum verwendet werden.
616-220-00-0
Pencycuron (ISO);
1-[(4-Chlorphenyl)methyl]-1-cyc-
lopentyl-3-phenylharnstoff
266-096-366063-05-6Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410 M = 1
M = 1
 
ab 01.12.2018*):
*) Die harmonisierten Einstufungen dürfen bereits vor dem genannten Datum verwendet werden.
616-221-00-6
Hexaflumuron (ISO);
1-(3,5-Dichlor-4-(1,1,2,2-
tetrafluorethoxy)phenyl)-
3-(2,6-difluorbenzoyl)
harnstoff
401-400-186479-06-3Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410 M = 1000
M = 10000
 
ab 01.12.2018*):
*) Die harmonisierten Einstufungen dürfen bereits vor dem genannten Datum verwendet werden.
616-222-00-1
Penthiopyrad (ISO);
(RS)-N-[2-(1,3-Dimethyl-
butyl)-3-thienyl]-1-methyl-3-
(trifluormethyl)pyrazol-4-
carboxamid
183675-82-3Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410 M = 1
M = 1
 
ab 01.12.2018*):
*) Die harmonisierten Einstufungen dürfen bereits vor dem genannten Datum verwendet werden.
616-223-00-7
Carbetamid (ISO);
(R)-1-(Ethylcarbamoyl)
ethylcarbanilat; (2R)-1-
(ethylamino)-1-oxopropan-2-
ylphenylcarbamat
240-286-616118-49-3Carc. 2
Repr. 1B
Acute Tox. 4
Aquatic Chronic 2
H351
H360D
H302
H411
GHS08
GHS07
GHS09
Dgr
H351
H360D
H302
H411
   
617-001-00-2di-tert-butyl peroxide203-733-6110-05-4Org. Perox. E
Flam. Liq. 2
Muta. 2
H242
H225
H341
GHS02
GHS08
Dgr
H242
H225
H341
   
617-002-00-8α,α-dimethyl-
benzyl hydroperoxide;
cumene hydroperoxide
201-254-780-15-9Org. Perox. E
Acute Tox. 3 (*)
Acute Tox. 4 (*)
Acute Tox. 4 (*)
STOT RE 2 (*)
Skin Corr. 1B
Aquatic Chronic 2
H242
H331
H312
H302
H373 (*)(*)
H314
H411
GHS02
GHS06
GHS08
GHS05
GHS09
Dgr
H242
H331
H312
H302
H373 (*)(*)
H314
H411
 Skin Corr. 1B;
H314: C ≥ 10 %
Skin Irrit. 2;
H315: 3 % ≤ C < 10 %
Eye Dam. 1;
H318: 3 % ≤ C < 10 %
Eye Irrit. 2; H319:
1% ≤ C < 3%
STOT SE 3;
H335: C < 10 %
 
617-003-00-3dilauroyl peroxide203-326-3105-74-8Org. Perox. DH242GHS02
Dgr
H242   
617-004-00-91,2,3,4-tetrahydro-1-naphthyl
hydroperoxide
212-230-0771-29-9Org. Perox. D
Acute Tox. 4 (*)
Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1
H242
H302
H314
H400
H410
GHS02
GHS05
GHS07
GHS09
Dgr
H242
H302
H314
H410
 STOT SE 3;
H335: C ≥ 5 %
 
617-006-00-Xbis(α,α-dimethyl-
benzyl) peroxide
201-279-380-43-3Org. Perox. F
Eye Irrit. 2
Skin Irrit. 2
Aquatic Chronic 2
H242
H319
H315
H411
GHS02
GHS07
GHS09
Wng
H242
H319
H315
H411